483
Evan Alley, M.D., Ph.D.FDA 483 - Evan Alley, M.D., Ph.D. - September 05, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Evan Alley, M.D., Ph.D. in Philadelphia revealed a significant deviation from the investigational plan and protocol. The principal investigator failed to obtain confirmation from the blinded independent committee review (BICR) for disease progression before discontinuing subjects from study treatment. This lapse occurred in multiple instances, indicating a failure to adhere to critical study procedures.
Open in Dashboard
ID · 2909eda3-98ab-448d-9b80-a8b34932d365